Temozad(Temozolomide)
Therapeutic class: alkylating agent
- Temozolomide is an alkylating drug indicated for the treatment of adult patients with:
- Newly diagnosed glioblastoma multiforme (GBM) concomitantly with radiotherapy and then as maintenance treatment.
- Refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.
20 mg , 100 mg & 250 mg Capsules
20 mg:- A bottle of 5 Capsules
100 mg:- A bottle of 5 Capsules
250 mg:- A bottle of 5 Capsules
- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
